002262 恩华药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)3.86313.77016.65217.20217.088
总资产报酬率 ROA (%)3.36511.97214.50515.01814.792
投入资产回报率 ROIC (%)3.65413.04015.92316.69616.598

边际利润分析
销售毛利率 (%)70.96772.12773.55872.82976.260
营业利润率 (%)22.18220.28623.45823.45223.344
息税前利润/营业总收入 (%)21.99619.55822.45822.79822.546
净利润/营业总收入 (%)19.72417.84620.02220.51520.474

收益指标分析
经营活动净收益/利润总额(%)100.80697.40599.77496.64994.928
价值变动净收益/利润总额(%)5.0595.2145.0574.3683.664
营业外收支净额/利润总额(%)-0.409-2.224-3.076-1.172-1.370

偿债能力分析
流动比率 (X)5.6945.9175.6836.4555.857
速动比率 (X)5.1185.2245.0635.6834.955
资产负债率 (%)13.45212.96013.82112.52813.847
带息债务/全部投入资本 (%)4.6164.0034.0961.6490.850
股东权益/带息债务 (%)2,044.3122,367.9712,309.8425,869.33511,456.128
股东权益/负债合计 (%)645.616674.048625.837700.820626.404
利息保障倍数 (X)-230.366-68.043-74.711-59.674-46.628

营运能力分析
应收账款周转天数 (天)90.30390.19879.76966.25162.707
存货周转天数 (天)139.766154.934154.132176.733232.955